Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation

Biology of Blood and Marrow Transplantation

Volumn 10, Issue 5, 2004, Pages 320-327

  Martin, Paul J ^a,b   McDonald, George B ^a,b   Sanders, Jean E ^a,c   Anasetti, Claudio ^a,b   Appelbaum, Frederick R ^a,b   Deeg, H Joachim ^a,b   Nash, Richard A ^a,b   Petersdorf, Effie W ^a,b   Hansen, John A ^a,b   Storb, Rainer ^a,b  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

Gastrointestinal; Graft versus host disease; Hematopoietic cell transplantation; HLA identical sibling donor

Indexed keywords

ACICLOVIR; ANTIBIOTIC AGENT; BUSULFAN; COTRIMOXAZOLE; CYCLOSPORIN; FLUCONAZOLE; GANCICLOVIR; HLA ANTIGEN; IMMUNOGLOBULIN; METHOTREXATE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ALLELE; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; AWARENESS; BACTERIAL INFECTION; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CHILD; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; DISEASE SEVERITY; DONOR; ENDOSCOPIC BIOPSY; FEMALE; GASTROINTESTINAL BIOPSY; GASTROINTESTINAL DISEASE; GRAFT VERSUS HOST REACTION; HLA MATCHING; HODGKIN DISEASE; HUMAN; INCIDENCE; INFANT; MAJOR CLINICAL STUDY; MALE; MYCOSIS; MYELODYSPLASTIC SYNDROME; MYELOMA; NONHODGKIN LYMPHOMA; PARENTERAL NUTRITION; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PNEUMOCYSTIS CARINII; PNEUMOCYSTIS PNEUMONIA; SENSITIVITY ANALYSIS; SIBLING; SKIN DISEASE; WHOLE BODY RADIATION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; EARLY DIAGNOSIS; FEMALE; GASTROINTESTINAL DISEASES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOCOMPATIBILITY TESTING; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INCIDENCE; INFANT; MALE; MIDDLE AGED; PARENTERAL NUTRITION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SIBLINGS; SURVIVAL RATE; TIME; TRANSPLANTATION, HOMOLOGOUS;

EID: 11144355404     PISSN: 10838791     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbmt.2003.12.304     Document Type: Article

References (33)

1. Glucksberg H. Storb R. Fefer A. et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors Transplantation 18 1974 295-304
2. Przepiorka D. Weisdorf D. Martin P. et al. Consensus conference on acute GVHD grading Bone Marrow Transplant 15 1995 825-828
3. Rowlings P.A. Przepiorka D. Klein J.P. et al. IBMTR Severity Index for grading acute graft-versus-host disease: retrospective comparison with Glucksberg grade Br J Haematol 97 1997 855-864
4. Martin P. Nash R. Sanders J. et al. Reproducibility in retrospective grading of acute graft-versus-host disease after allogeneic marrow transplantation Bone Marrow Transplant 21 1998 273-279
5. Al-Ghamdi H. Leisenring W. Bensinger W.I. et al. A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest Br J Haematol 113 2001 461-469
6. Storb R. Deeg H.J. Whitehead J. et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia N Engl J Med 314 1986 729-735
7. Storb R. Deeg H.J. Farewell V. et al. Marrow transplantation for severe aplastic anemia: methotrexate alone compared with a combination of methotrexate and cyclosporine for prevention of acute graft-versus-host disease Blood 68 1986 119-125
8. Storb R. Deeg H.J. Pepe M. et al. Methotrexate and cyclosporine versus cyclosporine alone for prophylaxis of graft-versus-host disease in patients given HLA-identical marrow grafts for leukemia: long-term follow-up of a controlled trial Blood 73 1989 1729-1734
9. Storb R. Deeg H.J. Pepe M. et al. Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: long-term follow-up of a controlled trial Br J Haematol 72 1989 567-572
10. Petersdorf E.W. Gooley T.A. Anasetti C. et al. Optimizing outcome after unrelated marrow transplantation by comprehensive matching of HLA class I and II alleles in the donor and recipient Blood 92 1998 3515-3520
11. Clift R.A. Buckner C.D. Appelbaum F.R. et al. Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens Blood 76 1990 1867-1871
12. Clift R.A. Buckner C.D. Appelbaum F.R. et al. Allogeneic marrow transplantation in patients with chronic myeloid leukemia in the chronic phase: a randomized trial of two irradiation regimens Blood 77 1991 1660-1665
13. Clift R.A. Buckner C.D. Thomas E.D. et al. Marrow transplantation for chronic myeloid leukemia: a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide Blood 84 1994 2036-2043
14. Goodrich J.M. Bowden R.A. Fisher L. Keller C. Schoch G. Meyers J.D. Ganciclovir prophylaxis to prevent cytomegalovirus disease after allogeneic marrow transplant Ann Intern Med 118 1993 173-178
15. Goodrich J.M. Boeckh M. Bowden R. Strategies for the prevention of cytomegalovirus disease after marrow transplantation Clin Infect Dis 19 1994 287-298
16. Slavin M.A. Osborne B. Adams R. et al. Efficacy and safety of fluconazole for fungal infections after marrow transplant-a prospective, randomized, double-blind study J Infect Dis 171 1995 1545-1552
17. Marr K.A. Seidel K. Slavin M. et al. Prolonged fluconazole prophylaxis is associated with persistent protection against candidiasis-related death in allogeneic marrow transplant recipients: long-term follow-up of a randomized, placebo-controlled trial Blood 96 2000 2055-2061
18. Sullivan K.M. Kopecky K.J. Jocom J. et al. Immunomodulatory and antimicrobial efficacy of intravenous immunoglobulin in bone marrow transplantation N Engl J Med 323 1990 705-712
19. Feinstein L.C. Seidel K. Jocum J. et al. Reduced dose intravenous immunoglobulin does not decrease transplant-related complications in adults given related donor marrow allografts Biol Blood Marrow Transplant 5 1999 369-378
20. Storb R. Prentice R.L. Buckner C.D. et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment N Engl J Med 308 1983 302-307
21. Nash R.A. Pepe M.S. Storb R. et al. Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate Blood 80 1992 1838-1845
22. Cox G.J. Matsui S.M. Lo R.S. et al. Etiology and outcome of diarrhea after marrow transplantation: a prospective study Gastroenterology 107 1994 1398-1407
23. Spencer G.D. Hackman R.C. McDonald G.B. et al. A prospective study of unexplained nausea and vomiting after marrow transplantation Transplantation 42 1986 602-607
24. Weisdorf D.J. Snover D.C. Haake R. et al. Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy Blood 76 1990 624-629
25. Wu D. Hockenbery D.M. Brentnall T.A. et al. Persistent nausea and anorexia after marrow transplantation: a prospective study of 78 patients Transplantation 66 1998 1319-1324
26. Bensinger W.I. Martin P.J. Storer B. et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers N Engl J Med 344 2001 175-181
27. Cutler C. Giri S. Jeyapalan S. Paniagua D. Visvanathan A. Antin J.H. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: a meta-analysis J Clin Oncol 19 2001 3685-3691
28. Petersen F.B. Buckner C.D. Clift R.A. et al. Infectious complications in patients undergoing marrow transplantation: a prospective randomized study of the additional effect of decontamination and laminar air flow isolation among patients receiving prophylactic systemic antibiotics Scand J Infect Dis 19 1987 559-567
29. Beelen D.W. Haralambie E. Brandt H. et al. Evidence that sustained growth suppression of intestinal anaerobic bacteria reduces the risk of acute graft-versus-host disease after sibling marrow transplantation Blood 80 1992 2668-2676
30. Spencer G.D. Shulman H.M. Myerson D. Thomas E.D. Diffuse intestinal ulceration after marrow transplantation: a clinical pathologic study of 13 patients Hum Pathol 17 1986 621-633
31. Schwartz J.M. Wolford J.L. Thornquist M.D. et al. Severe gastrointestinal bleeding after hematopoietic cell transplantation, 1987-1997: incidence, causes, and outcome Am J Gastroenterol 96 2001 385-393
32. Snover D.C. Mucosal damage simulating acute graft-versus-host reaction in cytomegalovirus colitis Transplantation 39 1985 669-670
33. Ponec R.J. Hackman R.C. McDonald G.B. Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation Gastrointest Endosc 49 1999 612-621